Randall C. Schatzman - Dec 31, 2023 Form 5 Insider Report for Bolt Biotherapeutics, Inc. (BOLT)

Role
Chief Executive Officer, Director
Signature
/s/ William P. Quinn, Attorney-in-Fact
Stock symbol
BOLT
Transactions as of
Dec 31, 2023
Transactions value $
$4,909
Form type
5
Date filed
2/6/2024, 01:08 PM
Previous filing
Feb 28, 2023
Next filing
Mar 6, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BOLT Common Stock Purchase $2.95K +2.5K +31.81% $1.18 10.4K Jun 6, 2023 Direct F1
transaction BOLT Common Stock Purchase $1.96K +2.5K +24.13% $0.78 12.9K Dec 6, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares acquired under the issuer's Employee Stock Purchase Plan.